MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
17.64%
Quick Ratio
17.64%
Debt to Asset Ratio
209.56%
Unit: Dollar
Assets Breakdown
Patent (net of amortization)
Vat receivable
Prepaid expenses
Others
Liabilities Breakdown
Accumulated deficit
Additional paid-in capital
Accounts payable and accrued exp...
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash
205,035
917,552
269,830
1,876,626
Employee advances
-
-
-
41,852
Prepaid expenses
337,707
-
63,082
403,213
Vat receivable
3,097,825
-
-
-
Total current assets
3,640,567
917,552
332,912
2,321,691
Fixed assets (net)
1,100
1,795
2,490
3,185
Patent (net of amortization)
6,255,646
6,379,889
6,504,132
6,628,375
Total-long term assets
6,256,746
6,381,684
6,506,622
-
Total assets
9,897,313
7,299,236
6,839,534
8,953,251
Accounts payable
-
-
9,936,387
3,374,287
Accrued expenses
-
-
1,415,002
395,450
Accounts payable and accrued expenses
20,247,881
15,233,838
-
-
Accrued payroll and payroll taxes related party
14,740
-
36,792
-
Accrued payroll and payroll taxes
3,622
989
1,279
614
Preferred dividends payable
375,000
375,000
375,000
375,000
Convertible notes
-
1,342,942
-
-
Total current liabilities
20,641,243
16,952,769
11,764,460
4,145,351
Tedco grant
100,000
100,000
100,000
100,000
Total long-term liabilities
100,000
100,000
100,000
100,000
Total liabilities
20,741,243
17,052,769
11,864,460
4,245,351
Series a convertible preferred stock, par value 0.001, 2,500,000 shares authorized 392,500 and 392,500 issued and outstanding, respectively
1,070,705
1,070,705
1,070,705
1,070,705
Total mezzanine equity
1,070,705
1,070,705
1,070,705
1,070,705
Common stock, par value 0.001, 150,000,000 shares authorized 45,283,071 and 37,113,082 issued and outstanding, respectively
45,283
39,278
37,116
33,270
Additional paid-in capital
74,255,518
66,719,534
61,053,472
57,329,311
Accumulated deficit
-86,215,436
-77,583,050
-67,186,219
-53,725,386
Total stockholders deficit
-11,914,635
-10,824,238
-6,095,631
3,637,195
Total liabilities, mezzanine equity and stockholders deficit
9,897,313
7,299,236
6,839,534
8,953,251
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Patent (net of
amortization)
$6,255,646
(-7.36%↓ Y/Y)
Fixed assets (net)
$1,100
(-71.65%↓ Y/Y)
Vat receivable
$3,097,825
Prepaid expenses
$337,707
(-55.09%↓ Y/Y)
Cash
$205,035
(-92.68%↓ Y/Y)
Total-long term assets
$6,256,746
Total current assets
$3,640,567
(2.44%↑ Y/Y)
Total assets
$9,897,313
(-4.01%↓ Y/Y)
Accumulated deficit
-$86,215,436
(-84.04%↓ Y/Y)
Total liabilities,
mezzanine equity and...
$9,897,313
(-4.01%↓ Y/Y)
Total stockholders
deficit
-$11,914,635
(-341.01%↓ Y/Y)
Additional paid-in capital
$74,255,518
(43.46%↑ Y/Y)
Common stock, par value
0.001, 150,000,000...
$45,283
(52.65%↑ Y/Y)
Total liabilities
$20,741,243
(482.94%↑ Y/Y)
Total mezzanine
equity
$1,070,705
(-40.81%↓ Y/Y)
Total current
liabilities
$20,641,243
(496.91%↑ Y/Y)
Total long-term
liabilities
$100,000
(0.00%↑ Y/Y)
Series a convertible
preferred stock, par value...
$1,070,705
(-40.81%↓ Y/Y)
Accounts payable and
accrued expenses
$20,247,881
Preferred dividends
payable
$375,000
(0.00%↑ Y/Y)
Accrued payroll and
payroll taxes related...
$14,740
Accrued payroll and
payroll taxes
$3,622
Tedco grant
$100,000
(0.00%↑ Y/Y)
Buy us a coffee
OS Therapies Inc (OSTX)
OS Therapies Inc (OSTX)